VOLITIONRX LTD·4

Sep 19, 4:28 PM ET

Vanston David Cecil 4

4 · VOLITIONRX LTD · Filed Sep 19, 2017

Insider Transaction Report

Form 4
Period: 2017-09-19
Vanston David Cecil
Chief Financial Officer
Transactions
  • Purchase

    COMMON STOCK

    2017-09-19$2.84/sh+2,750$7,8102,750 total

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT